http://www.newstin.com/us/male-health Global Social News Platform Copyright © 2006 I2S a.s. Copyright © 2006 I2S a.s. http://www.newstin.com/tag/us/57482145 Posted on: Thursday, 15 May 2008, 21:00 CDT SAN FRANCISCO, May 15 /PRNewswire-FirstCall/ -- Medivation, Inc. today announced that data from an ongoing Phase 1-2 clinical trial of its novel androgen receptor antagonist, MDV3100, will be presented in an oral presentation at the 44th American... Fri, 16 May 2008 02:00:06 GMT http://www.newstin.com/tag/us/57482145 2008-05-16T02:00:06Z http://www.newstin.com/tag/us/57482184 Posted on: Thursday, 15 May 2008, 21:00 CDT SOUTH SAN FRANCISCO, Calif., May 15 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. , a biopharmaceutical company focused on oncology, today announced that the Company will present data from three clinical trials of picoplatin, in various tumor... Fri, 16 May 2008 02:00:06 GMT http://www.newstin.com/tag/us/57482184 2008-05-16T02:00:06Z http://www.newstin.com/tag/us/57466236 Description The following news tips are based on abstracts or poster presentations at the annual meeting of the American Society of Clinical Oncology (ASCO) to be held in Chicago, Illinois, May 30 – June 3, 2008. Study Tracks a Biomarker for Early Detection of Malignant Pleural Mesothelioma... Fri, 16 May 2008 01:18:03 GMT http://www.newstin.com/tag/us/57466236 2008-05-16T01:18:03Z http://www.newstin.com/tag/us/57509992 Erectile Dysfunction may call up Coronary Artery Disease According to European Heart Journal Erectile Dysfunction more prone to be happening with men who have severe coronary artery disease. Basically Erectile Dysfunction is cardiovascular disorder often lead to other cardiovascular diseases,... Fri, 16 May 2008 08:56:00 GMT http://www.newstin.com/tag/us/57509992 2008-05-16T08:56:00Z http://www.newstin.com/tag/us/57520053 Home erectile dysfunction medications SoftV is a non-prescription, over-the-counter, risk-free, herbal remedy used for Erectile Dysfunction. It is a well researched sublingual formula, to be placed under the tongue and be allowed to dissolve completely. SoftV is quickly assimilated into the body,... Fri, 16 May 2008 09:53:07 GMT http://www.newstin.com/tag/us/57520053 2008-05-16T09:53:07Z http://www.newstin.com/tag/us/57451236 16 May 2008 - AEterna Zentaris Inc. reported dosing has commenced in the safety study of the Company's Phase 3 program with cetrorelix in benign prostatic hyperplasia (BPH). Cetrorelix, a novel investigational luteinizing hormone-releasing hormone (LHRH) antagonist, is the Company's flagship... Thu, 15 May 2008 22:26:09 GMT http://www.newstin.com/tag/us/57451236 2008-05-15T22:26:09Z http://www.newstin.com/tag/us/57474548 Advanced Medical Institute Inc. (OTCBB:AVMD) (AMI), a leading provider of treatment for Erectile Dysfunction and Premature Ejaculation in Australia and New Zealand, has announced results for the fiscal quarter and nine months ended March 31, 2008. For the nine months ended March 31, 2008, as... Fri, 16 May 2008 02:56:29 GMT http://www.newstin.com/tag/us/57474548 2008-05-16T02:56:29Z http://www.newstin.com/tag/us/57374065 Prostate Cancer Treatment and Symptoms There is strong need for prostate cancer reliable clinical predictors for the progression of disease. Researchers presented their findings to the media on May 18, 2008 at 11:00 a.m. Researchers from the University of Texas Health Science Center in San... Thu, 15 May 2008 12:22:58 GMT http://www.newstin.com/tag/us/57374065 2008-05-15T12:22:58Z http://www.newstin.com/tag/us/57381281 Erectile Dysfunction and Impotence Treatment Maxi-K gene therapy may be a safe and effective future treatment for men whose erectile dysfunction (ED) is not treatable with oral therapy. Researchers presented their findings to reporters in a special press conference on May 20, 2008 at 10 a.m.... Thu, 15 May 2008 13:16:21 GMT http://www.newstin.com/tag/us/57381281 2008-05-15T13:16:21Z http://www.newstin.com/tag/us/57360685 First Quarter 2008 Highlights: * Total HIFU revenue of EUR 2.2 million, up 39% year-over-year * Gross margin increased to 44.1% compared to 43.1% in the first quarter of 2007 * Continued progress in U.S. ENLIGHT clinical study driven by IRB approval of 11 premier Ablatherm and 8 Cryotherapy sites... Thu, 15 May 2008 11:00:00 GMT http://www.newstin.com/tag/us/57360685 2008-05-15T11:00:00Z